Oruka Therapeutics, Inc. ORKA Common stock, capital shares reserved for future issuance
Common stock, capital shares reserved for future issuance at other companies
Other financials
Where this comes from
Reported directly by Oruka Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:CommonStockCapitalSharesReservedForFutureIssuance.
The official record: Oruka Therapeutics, Inc.’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →
Ask your AI about Oruka Therapeutics, Inc.'s common stock, capital shares reserved for future issuance.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Oruka Therapeutics, Inc.'s common stock, capital shares reserved for future issuance?
- Oruka Therapeutics, Inc. (ORKA) reported common stock, capital shares reserved for future issuance of $34.85M in Q1 2026.
- How has Oruka Therapeutics, Inc.'s common stock, capital shares reserved for future issuance changed year-over-year?
- Oruka Therapeutics, Inc.'s common stock, capital shares reserved for future issuance increased by 12.9% year-over-year, from $30.86M to $34.85M.